Protocatechuic acid treatment also inhibited the expression of MMP-3 and MMP-13 in RA-FLSs, as well as the secretion of inflammatory cytokines TNF-α, IL-1β, and IL-6. The gene discussed is MMP13; the disease is rheumatoid arthritis.